• RSV NS3 Rewires Host Signaling for Transmission

  2026-09-04

  The 2025 Developmental Cell study shows that Rice stripe virus NS3 dynamically exploits the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway to balance pathogenicity, host survival, and transmission. Its stage-dependent phosphorylation and interaction behavior provides a mechanistic model for long-term co-survival across rice, the planthopper vector, and related hosts.

• Norovirus Co-opts NINJ1 for Selective NS1 Secretion

  2026-09-04

  Song and colleagues show that murine norovirus exploits NINJ1-mediated plasma membrane rupture to release the viral NS1 protein while also permitting broader DAMP release. The study connects caspase-3 cleavage, NINJ1 recruitment to viral replication sites, and NS1 interaction residues to an unconventional secretion pathway with consequences for intestinal infection.

• O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia

  2026-09-04

  The reference study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links protein modification to iron handling, ferroptosis, and trophoblast syncytialization in preeclampsia. Its combined proteomic, cellular, and animal evidence provides a mechanistic framework for studying placental stress while also defining important limits for translation.

• Belinostat (PXD101): HDAC Inhibition Benchmarks

  2026-09-03

  Belinostat, also called PXD101, is a hydroxamate-type pan-histone deacetylase inhibitor with nanomolar biochemical activity and measurable antiproliferative effects in bladder and prostate cancer models. This article separates validated product benchmarks from research hypotheses involving epigenetic cancer therapy, spliceosome acetylation, and DNA-damage response.

• Berberine Hydrochloride: Assay Reliability

  2026-09-02

  This scenario-driven guide explains how Berberine Hydrochloride, SKU N1368, can improve experimental control in cell viability, proliferation, cytotoxicity, and metabolic assays. It covers mechanism-aware assay design, DMSO stock preparation, interpretation of AMPK-linked effects, and practical criteria for selecting a reliable reagent.

• Gemcitabine HCl: From Potency to Tumor Evidence

  2026-09-02

  Gemcitabine HCl research is strongest when molecular cytotoxicity data are connected to longitudinal tumor measurements. This article presents an evidence-centered framework linking DNA replication inhibition, cell-death assays, and multianimal MRI in pancreatic cancer models.

• Bsa I (RNase-free): Practical Workflow Guide

  2026-09-01

  Bsa I (RNase-free) provides sequence-specific DNA cleavage for cloning and other molecular biology research workflows in which RNA contamination must be minimized. It is intended for controlled scientific use, not diagnostic, clinical, or medical applications, and reaction conditions should be validated for each DNA substrate.

• Mouse Neutrophil Cell Isolation Kit for Tumor Studies

  2026-09-01

  Build cleaner tumor-immunology assays with high-purity, minimally perturbed mouse neutrophils from bone marrow, blood, or spleen. This negative-selection workflow is especially useful for testing neutrophil-targeted mRNA nanovaccines, functional co-cultures, and activation-sensitive endpoints.

• Nadolol (SQ-11725) in Cell Assays

  2026-08-31

  Learn how Nadolol (SQ-11725), SKU BA5097, can be incorporated into reproducible viability, proliferation, and beta-adrenergic signaling workflows. This scenario-based guide emphasizes controls, transporter-aware interpretation, solution handling, and evidence-based product selection.

• Bradford Protein Assay Kit: Practical Protocol

  2026-08-31

  The Bradford Protein Assay Kit (K4103) provides rapid protein concentration measurement from small-volume solution samples using Coomassie Brilliant Blue G-250 and BSA standards. It is suited to clear, compatible samples in biochemical and molecular biology workflows, but samples containing incompatible detergents, chemicals, substantial turbidity, or nonprotein analytes require remediation or a different assay.

• Sex Differences in Angiotensin II Hypertension

  2026-08-30

  Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II infusion produces substantially greater hypertension in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade linked this divergence to sex-dependent hormonal and autonomic regulation, providing a useful framework for studying sex as a biological variable in hypertension.

• Sabutoclax: Separating Growth Arrest from Cell Death

  2026-08-29

  Sabutoclax is a pan-Bcl-2 inhibitor whose apparent potency depends on whether an assay measures reduced viability, proliferation arrest, or actual cell death. This evidence-led guide shows how to design and interpret Sabutoclax experiments without conflating these distinct biological outcomes.

• 3D Cardiac Organoid Mapping with Shell MEAs

  2026-08-28

  The reference study introduces shape-adaptive shell microelectrode arrays that surround cardiac organoids and record electrical activity across three dimensions. By combining high-resolution activation mapping, conduction-velocity analysis, calcium imaging, and pharmacological perturbation, the platform extends cardiac electrophysiology research beyond the planar limits of conventional microelectrode arrays.

• Amorolfine Hydrochloride in Yeast Integrity Studies

  2026-08-28

  Use Amorolfine Hydrochloride as a timed membrane-biosynthesis perturbation to separate ploidy-associated surface stress from baseline growth defects in budding yeast. This workflow combines controlled dosing, DNA-content confirmation, membrane phenotyping, and transcript-level follow-up for fungal infection research and antifungal resistance studies.

• EPZ-6438 Workflow for EZH2 Inhibition

  2026-08-27

  EPZ-6438 is a selective EZH2 inhibitor for connecting PRC2 activity with H3K27me3, transcriptional, and cancer-cell phenotypes. This practical workflow shows how to deploy it across HPV-associated cervical cancer, malignant rhabdoid tumor, and EZH2-mutant lymphoma models while avoiding common solubility and assay-design failures.

7930 records 1/529 page Next 12345 下5页 Last page